BACKGROUND: Mutations in the SLC26A4 gene, coding for the anion transporter pendrin, are responsible for Pendred syndrome, characterized by congenital sensorineural deafness and dyshormonogenic goiter. The physiological role of pendrin in the thyroid is still unclear and the lack of a thyroid phenotype in some patients with SLC26A4 mutations and in Slc26a4 (-/-) mice indicate the existence of environmental or individual modifiers able to compensate for pendrin inactivation in the thyroid. Since pendrin can transport iodide in vitro, variations in iodide supply have been claimed to account for the thyroid phenotype associated with pendrin defects. AIM: The Slc26a4 (-/-) mouse model was used to test the hypothesis that iodide supply may influence the penetrance and expressivity of SLC26A4 mutations. MATERIALS AND METHODS: Slc26a4 (-/-) and (+/+) mice were fed up to 6 months on a standard or low iodine diet and were evaluated for thyroid structural abnormalities or biochemical hypothyroidism. RESULTS: A 27-fold iodide restriction induced similar modifications in thyroid histology, but no differences in thyroid size, T4 or TSH levels were observed between between Slc26a4 (-/-) and (+/+) mice, either in standard conditions and during iodine restriction. CONCLUSIONS: Iodide restriction is not able to induce a thyroid phenotype in Slc26a4 (-/-) mice. These experimental data, together with those coming from a review of familial Pendred cases leaving in regions either with low or sufficient iodide supply, support the idea that the expression of thyroid phenotype in Pendred syndrome is more powerfully influenced by individual factors than by dietary iodide.
BACKGROUND: Mutations in the SLC26A4 gene, coding for the anion transporter pendrin, are responsible for Pendred syndrome, characterized by congenital sensorineural deafness and dyshormonogenic goiter. The physiological role of pendrin in the thyroid is still unclear and the lack of a thyroid phenotype in some patients with SLC26A4 mutations and in Slc26a4 (-/-) mice indicate the existence of environmental or individual modifiers able to compensate for pendrin inactivation in the thyroid. Since pendrin can transport iodide in vitro, variations in iodide supply have been claimed to account for the thyroid phenotype associated with pendrin defects. AIM: The Slc26a4 (-/-) mouse model was used to test the hypothesis that iodide supply may influence the penetrance and expressivity of SLC26A4 mutations. MATERIALS AND METHODS:Slc26a4 (-/-) and (+/+) mice were fed up to 6 months on a standard or low iodine diet and were evaluated for thyroid structural abnormalities or biochemical hypothyroidism. RESULTS: A 27-fold iodide restriction induced similar modifications in thyroid histology, but no differences in thyroid size, T4 or TSH levels were observed between between Slc26a4 (-/-) and (+/+) mice, either in standard conditions and during iodine restriction. CONCLUSIONS:Iodide restriction is not able to induce a thyroid phenotype in Slc26a4 (-/-) mice. These experimental data, together with those coming from a review of familial Pendred cases leaving in regions either with low or sufficient iodide supply, support the idea that the expression of thyroid phenotype in Pendred syndrome is more powerfully influenced by individual factors than by dietary iodide.
Authors: O Gonzalez Trevino; O Karamanoglu Arseven; C J Ceballos; V I Vives; R C Ramirez; V V Gomez; G Medeiros-Neto; P Kopp Journal: Eur J Endocrinol Date: 2001-06 Impact factor: 6.664
Authors: I E Royaux; S M Wall; L P Karniski; L A Everett; K Suzuki; M A Knepper; E D Green Journal: Proc Natl Acad Sci U S A Date: 2001-03-27 Impact factor: 11.205
Authors: L A Everett; I A Belyantseva; K Noben-Trauth; R Cantos; A Chen; S I Thakkar; S L Hoogstraten-Miller; B Kachar; D K Wu; E D Green Journal: Hum Mol Genet Date: 2001-01-15 Impact factor: 6.150
Authors: L Fugazzola; D Mannavola; N Cerutti; M Maghnie; F Pagella; P Bianchi; G Weber; L Persani; P Beck-Peccoz Journal: J Clin Endocrinol Metab Date: 2000-07 Impact factor: 5.958
Authors: J M Bidart; C Mian; V Lazar; D Russo; S Filetti; B Caillou; M Schlumberger Journal: J Clin Endocrinol Metab Date: 2000-05 Impact factor: 5.958
Authors: Philine Wangemann; Kazuhiro Nakaya; Tao Wu; Rajanikanth J Maganti; Erin M Itza; Joel D Sanneman; Donald G Harbidge; Sara Billings; Daniel C Marcus Journal: Am J Physiol Renal Physiol Date: 2007-02-13
Authors: S Masmoudi; I Charfedine; M Hmani; M Grati; A M Ghorbel; A Elgaied-Boulila; M Drira; J P Hardelin; H Ayadi Journal: Am J Med Genet Date: 2000-01-03
Authors: P Van Hauwe; L A Everett; P Coucke; D A Scott; M L Kraft; C Ris-Stalpers; C Bolder; B Otten; J J de Vijlder; N L Dietrich; A Ramesh; S C Srisailapathy; A Parving; C W Cremers; P J Willems; R J Smith; E D Green; G Van Camp Journal: Hum Mol Genet Date: 1998-07 Impact factor: 6.150
Authors: P Kopp; O K Arseven; L Sabacan; T Kotlar; J Dupuis; H Cavaliere; C L Santos; J L Jameson; G Medeiros-Neto Journal: J Clin Endocrinol Metab Date: 1999-01 Impact factor: 5.958
Authors: Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco Journal: Annu Rev Physiol Date: 2017-02-10 Impact factor: 19.318
Authors: Liuska Pesce; Aigerim Bizhanova; Juan Carlos Caraballo; Whitney Westphal; Maria L Butti; Alejandro Comellas; Peter Kopp Journal: Endocrinology Date: 2011-11-22 Impact factor: 4.736
Authors: Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic Journal: Am J Physiol Renal Physiol Date: 2011-11-30
Authors: Giuseppe Ferrandino; Rachel R Kaspari; Andrea Reyna-Neyra; Nabil E Boutagy; Albert J Sinusas; Nancy Carrasco Journal: Sci Rep Date: 2017-07-13 Impact factor: 4.379